medigraphic.com
ISSN 2539-0859 (Electronic)
ISSN 0120-8411 (Print)
Asociación Colombiana de Otorrinolaringología y Cirugía de Cabeza y cuello, Maxilofacial y Estética Facial (ACORL)

2023, Number 1

<< Back Next >>

Acta de Otorrinolaringología CCC 2023; 51 (1)

Virtual screening of secondary metabolites of Origanum vulgare and marjoram against NaV1.7 as promising anesthetics associated with the auditory neurosensory pathway

Vélez-Duncan CA, Uribe-Escobar A, Pineda-Alemán R, Contreras-Puentes N, Alviz-Amador A

Language: Spanish
References: 26
Page: 29-34
PDF size: 275.71 Kb.


ABSTRACT

Introduction: In general, oregano is a medicinal plant used in rural areas of the colombian Caribbean coast to treat conditions of the respiratory system and external ear due to its potential anti-inflammatory, analgesic and antiseptic effect, however, it has not been validated through clinical trials. Objective: To carry out a virtual screening based on molecular coupling of secondary metabolites identified in Origanum vulgare and marjoram against the Nav1.7 receptor to evaluate the potential anesthetic effect at the level of the external ear. Method: This is an in-silico study with a virtual molecular docking screening approach, for which the AutoDock Vina software was used and the Swiss Institute of Bioinformatics (http://www.sib.swiss) online tool SwissADME was used for pharmacokinetic predictions. Additionally, the in-silico toxicity of the molecules was evaluated using the GUSAR-Online server. Results: Of the 99 molecules that were evaluated by molecular coupling, it was shown that the highest affinities with respect to the Nav1.7 channel were chlorogenic acid, rutin, luteolin, luteoside and apigenin, where affinity energies were presented with the binding site in the central pore of the channel at values between -5.40 ± 0.00 to -5.57 ± 0.06 kcal/mol, which according to the ADMET and GUSAR analysis, only chlorogenic acid, luteolin and apigenin are good potential candidates for anesthetic drugs complying with the 5 rules of Lipinsky. Conclusion: Based on the phytochemical studies of O. vulgare and marjoram that have reported the secondary metabolites present in the extracts of these plants, their coupling to the Nav1.7 channel expressed in the neurosensory pathway of the ear was evidenced in this in-silico study. It was also shown that chlorogenic acid, luteolin and apigenin could be potential local anesthetic drugs for ear conditions.


REFERENCES

  1. Soria N, Ramos P. Uso de plantas medicinales en la AtenciónPrimaria de Salud en Paraguay: algunas consideracionespara su uso seguro y eficaz. Mem. Inst. Invest. Cienc. Salud.

  2. 2015;13(2):8-17.2. Bouyahya A, Chamkhi I, Benali T, Guaouguaou FE, Balahbib A,El Omari N, et al. Traditional use, phytochemistry, toxicology,and pharmacology of Origanum majorana L. J Ethnopharmacol.2021;265:113318. doi: 10.1016/j.jep.2020.113318

  3. Rezaie A, Jafari B, Mousavi G, Nazeri M, Ebadi A, AhmadehC, et al. Comparative Study of Sedative, Pre-Anesthetic andAnti-Anxiety Effect of Origanum majorana Extract withDiazepam on Rats. Res J Biol Sci. 2011;6(11):611-4. doi:10.3923/rjbsci.2011.611.614

  4. Chuang LT, Tsai TH, Lien TJ, Huang WC, Liu JJ, Chang H,et al. Ethanolic Extract of Origanum vulgare SuppressesPropionibacterium acnes-Induced Inflammatory Responses inHuman Monocyte and Mouse Ear Edema Models. Molecules.2018;23(8):1987. doi: 10.3390/molecules23081987

  5. Fryatt AG, Vial C, Mulheran M, Gunthorpe MJ, Grubb BD.Voltage-gated sodium channel expression in rat spiral ganglionneurons. Mol Cell Neurosci. 2009;42(4):399-07. doi: 10.1016/j.mcn.2009.09.001

  6. Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A,et al. PubChem Substance and Compound databases. NucleicAcids Res. 2016;44(D1):D1202-13. doi: 10.1093/nar/gkv951

  7. O’Boyle NM, Banck M, James CA, Morley C, VandermeerschT, Hutchison GR. Open Babel: An open chemical toolbox. JCheminform. 2011;3:33. doi: 10.1186/1758-2946-3-33

  8. Ahuja S, Mukund S, Deng L, Khakh K, Chang E, Ho H, et al.Structural basis of Nav1.7 inhibition by an isoform-selectivesmall-molecule antagonist. Science. 2015;350(6267):aac5464.doi: 10.1126/science.aac5464

  9. Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G,Gumienny R, et al. SWISS-MODEL: Homology modellingof protein structures and complexes. Nucleic Acids Res.2018;46(W1):W296–303. doi: 10.1093/nar/gky427

  10. Trott O, Olson AJ. AutoDock Vina: improving the speedand accuracy of docking with a new scoring function,efficient optimization, and multithreading. J Comput Chem.2010;31(2):455-61. doi: 10.1002/jcc.21334

  11. Laskowski RA, Swindells MB. LigPlot+: multiple ligandproteininteraction diagrams for drug discovery. J Chem InfModel. 2011;51(10):2778-86. doi: 10.1021/ci200227u

  12. Daina A, Michielin O, Zoete V. SwissADME: a free webtool to evaluate pharmacokinetics, drug-likeness andmedicinal chemistry friendliness of small molecules. Sci Rep.2017;7:42717. doi: 10.1038/srep42717

  13. Lagunin A, Zakharov A, Filimonov D, Poroikov V. QSARModelling of Rat Acute Toxicity on the Basis of PASSPrediction. Mol Inform. 2011;30(2-3):241-50. doi: 10.1002/minf.201000151

  14. Afarineshe Khaki MR, Pahlavan Y, Sepehri G, Sheibani V,Pahlavan B. Antinociceptive Effect of Aqueous Extract ofOriganum vulgare L. in Male Rats: Possible Involvement of theGABAergic System. Iran J Pharm Res. 2013;12(2):407-13.

  15. De Falco E, Mancini E, Roscigno G, Mignola E, Taglialatela-Scafati O, Senatore F. Chemical composition and biologicalactivity of essential oils of Origanum vulgare L. subsp.vulgare L. under different growth conditions. Molecules.2013;18(12):14948-60. doi: 10.3390/molecules181214948

  16. Lombrea A, Antal D, Ardelean F, Avram S, Pavel IZ, VlaiaL, et al. A Recent Insight Regarding the Phytochemistry andBioactivity of Origanum vulgare L. Essential Oil. Int J Mol Sci.2020;21(24):9653. doi: 10.3390/ijms21249653

  17. Tsuchiya H. Anesthetic Agents of Plant Origin: A Review ofPhytochemicals with Anesthetic Activity. Molecules. 2017 Aug

  18. 18;22(8):1369. doi: 10.3390/molecules2208136918. Taamalli A, Arráez-Román D, Abaza L, Iswaldi I, Fernández-Gutiérrez A, Zarrouk M, et al. LC-MS-based metaboliteprofiling of methanolic extracts from the medicinal andaromatic species Mentha pulegium and Origanum majorana.Phytochem Anal. 2015;26(5):320-30. doi: 10.1002/pca.2566

  19. Mahmoudian-Sani MR, Hashemzadeh-Chaleshtori M, Asadi-Samani M, Luther T. A Review of Medicinal Plants for theTreatment of Earache and Tinnitus in Iran. Int Tinnitus J.

  20. 2017;21(1):44-49. doi: 10.5935/0946-5448.2017000920. Gómez-Estrada H, Díaz-Castillo F, Franco-Ospina L, Mercado-Camargo J, Guzmán-Ledezma J, Medina JD, et al. Folkmedicine in the northern coast of Colombia: an overview. JEthnobiol Ethnomed. 2011;7:27. doi: 10.1186/1746-4269-7-27

  21. Cardona LM, Cardona LM, Díaz APS, Corrales JAP. Uso deplantas medicinales en enfermedades otorrinolaringológicas.Rev Cuba Otorrinolaringol y Cirugía Cabeza y Cuello.2020;4(3):1-13.

  22. Silva FV, Guimarães AG, Silva ER, Sousa-Neto BP, MachadoFD, Quintans-Júnior LJ, et al. Anti-inflammatory and anti-ulceractivities of carvacrol, a monoterpene present in the essentialoil of oregano. J Med Food. 2012;15(11):984-91. doi: 10.1089/jmf.2012.0102

  23. Ebani VV, Nardoni S, Bertelloni F, Najar B, Pistelli L,Mancianti F. Antibacterial and Antifungal Activity of EssentialOils against Pathogens Responsible for Otitis Externa in Dogsand Cats. Medicines (Basel). 2017;4(2):21. doi: 10.3390/medicines4020021

  24. Ghelardini C, Galeotti N, Mazzanti G. Local anaestheticactivity of monoterpenes and phenylpropanes of essential oils.Planta Med. 2001;67(6):564-6. doi: 10.1055/s-2001-16475

  25. da Cunha JA, Scheeren C, Salbego J, Gressler LT, MadalozLM, Bandeira Junior G, et al. Essential oils of Cunila galioidesand Origanum majorana as anesthetics for Rhamdia quelen:Efficacy and effects on ventilation and ionoregulation. NeotropIchthyol. 2017;15(1):e160076. doi: 10.1590/1982-0224-20160076

  26. Kakita K, Tsubouchi H, Adachi M, Takehana S, Shimazu Y,Takeda M. Local subcutaneous injection of chlorogenic acidinhibits the nociceptive trigeminal spinal nucleus caudalisneurons in rats. Neurosci Res. 2018;134:49-55. doi: 10.1016/j.neures.2017.11.009




2020     |     www.medigraphic.com